The North America AI In Medical Writing Market is expected to witness market growth of 11.6% CAGR during the forecast period (2024-2031).
The US market dominated the North America AI In Medical Writing Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $410.6 Million by 2031. The Canada market is experiencing a CAGR of 14% during 2024-2031. Additionally, the Mexico market is exhibiting a CAGR of 13% during 2024-2031.
The growing adoption of AI in medical writing is also driven by the increasing focus on data-driven decision-making in healthcare. AI tools can integrate data from diverse sources, including electronic health records, clinical trial databases, and scientific literature, to provide actionable insights. These insights are essential for creating documentation that reflects the latest scientific advancements and regulatory requirements.
Moreover, AI's ability to analyze real-world evidence and patient data has opened new avenues for creating personalized and contextually relevant content. For instance, AI can generate tailored patient education materials based on individual health profiles, ensuring the information is relevant and easily understandable.
The region has established itself as a significant participant in the market, collaborating with prominent pharmaceutical, biotechnology, and healthcare companies. The increasing demand for AI in medical writing market is significantly fueled by government initiatives and investments to modernize the pharmaceutical and healthcare industries. In the United States, programs such as the U.S. Department of Health and Human Services (HHS) "Health IT" initiative and the FDA’s "Emerging Technology Program" drive the integration of digital technologies into pharmaceutical workflows, including medical writing. According to the Congressional Budget Office, the U.S. pharmaceutical industry spent $83 billion on R&D in 2019, underscoring the need for AI-driven tools to manage the documentation generated from such investments.
The US market dominated the North America AI In Medical Writing Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $410.6 Million by 2031. The Canada market is experiencing a CAGR of 14% during 2024-2031. Additionally, the Mexico market is exhibiting a CAGR of 13% during 2024-2031.
The growing adoption of AI in medical writing is also driven by the increasing focus on data-driven decision-making in healthcare. AI tools can integrate data from diverse sources, including electronic health records, clinical trial databases, and scientific literature, to provide actionable insights. These insights are essential for creating documentation that reflects the latest scientific advancements and regulatory requirements.
Moreover, AI's ability to analyze real-world evidence and patient data has opened new avenues for creating personalized and contextually relevant content. For instance, AI can generate tailored patient education materials based on individual health profiles, ensuring the information is relevant and easily understandable.
The region has established itself as a significant participant in the market, collaborating with prominent pharmaceutical, biotechnology, and healthcare companies. The increasing demand for AI in medical writing market is significantly fueled by government initiatives and investments to modernize the pharmaceutical and healthcare industries. In the United States, programs such as the U.S. Department of Health and Human Services (HHS) "Health IT" initiative and the FDA’s "Emerging Technology Program" drive the integration of digital technologies into pharmaceutical workflows, including medical writing. According to the Congressional Budget Office, the U.S. pharmaceutical industry spent $83 billion on R&D in 2019, underscoring the need for AI-driven tools to manage the documentation generated from such investments.
List of Key Companies Profiled
- Parexel International (MA) Corporation
- Certara, Inc.
- Accenture PLC
- Smarter Dx, Inc.
- Corti ApS
- IQVIA Holdings, Inc.
- Abridge Al, Inc.
- Syneos Health, Inc.
- IBM Corporation
- Teladoc Health, Inc.
Market Report Segmentation
By Type- Type Writing
- Scientific Writing
- Clinical Writing
- Other Type
- Pharmaceutical
- Biotechnology
- Medical Devices
- Other End Use
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America AI In Medical Writing Market by Type
Chapter 6. North America AI In Medical Writing Market by End Use
Chapter 7. North America AI In Medical Writing Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Parexel International (MA) Corporation
- Certara, Inc.
- Accenture PLC
- Smarter Dx, Inc.
- Corti ApS
- IQVIA Holdings, Inc.
- Abridge Al, Inc.
- Syneos Health, Inc.
- IBM Corporation
- Teladoc Health, Inc.
Methodology
LOADING...
